Herpes Simplex Differential Diagnosis: A Comprehensive Guide for Clinicians

Introduction

Herpes simplex virus type 1 (HSV-1) is a ubiquitous human pathogen, responsible for a spectrum of clinical manifestations, ranging from mild, recurrent orolabial lesions to severe, life-threatening conditions such as herpes encephalitis. While many individuals infected with HSV-1 remain asymptomatic or experience infrequent, self-limiting outbreaks, others suffer from recurrent or severe disease. Accurate diagnosis is crucial for effective management, yet the varied clinical presentations of HSV-1 can often mimic other conditions, posing a diagnostic challenge. Therefore, a robust understanding of the Herpes Simplex Differential Diagnosis is paramount for clinicians to ensure timely and appropriate patient care. This article aims to provide a comprehensive overview of the differential diagnoses for various HSV-1 infections, enhancing diagnostic accuracy and guiding optimal treatment strategies in the English-speaking medical community.

Etiology and Risk Factors

Understanding the etiology and risk factors associated with HSV-1 infections is the first step in considering the differential diagnosis. HSV-1 transmission typically occurs through direct contact with infected saliva or mucous membranes. Risk factors vary depending on the clinical presentation:

• Orolabial Herpes: Transmission primarily occurs through non-sexual contact, such as kissing, sharing utensils, or close personal contact. Reactivation can be triggered by stress, fever, sunlight, or menstruation.
• Herpetic Sycosis: Shaving with a razor blade, especially during an active orolabial herpes outbreak, significantly increases the risk of follicular HSV-1 infection in the beard area.
• Herpes Gladiatorum: Direct skin-to-skin contact during contact sports like wrestling, rugby, and martial arts facilitates transmission.
• Herpetic Whitlow: Thumb sucking or nail-biting in children with oral HSV-1, and healthcare work in adults (though HSV-2 is more common in adults) are major risk factors.
• Herpes Encephalitis: Genetic predispositions, particularly mutations in TLR-3 and UNC-93B genes affecting interferon responses, are significant risk factors.
• Eczema Herpeticum: Pre-existing skin barrier dysfunction from conditions like atopic dermatitis, Darier disease, and ichthyosis, along with the use of topical calcineurin inhibitors, increase susceptibility.
• Severe or Chronic HSV Infection: Immunocompromised states, including HIV infection, organ transplantation, and hematologic malignancies, are the primary risk factors.

Epidemiology

HSV-1 is globally prevalent, with estimates suggesting that a significant portion of the world’s population is seropositive. Epidemiological considerations are important in the differential diagnosis, particularly in certain populations:

• Global Prevalence: Approximately one-third of the global population is estimated to experience symptomatic HSV-1 infection.
• Neonatal Herpes: While relatively rare, neonatal herpes (around 1 in 1000 US newborns) is a severe concern, primarily due to HSV exposure during vaginal delivery. Primary maternal infection during pregnancy poses a higher risk than recurrent infection.
• Herpes Encephalitis: Notably, herpes encephalitis remains the leading cause of fatal encephalitis in the United States.
• Ocular HSV Infection: Ocular HSV is a significant cause of corneal blindness in developed countries.

Pathophysiology

The pathophysiology of HSV-1 infection underlies its clinical manifestations and informs the differential diagnosis. After initial mucocutaneous infection, HSV-1 travels retrogradely to the dorsal root ganglia, establishing latency. Reactivation can occur due to various triggers, leading to recurrent infections. The virus’s ability to evade the immune system, including mechanisms like intercellular sequestration of CD1d molecules, contributes to its persistence and recurrent nature.

Histopathology

Histopathological findings, while not pathognomonic, can support the clinical suspicion of HSV-1 infection and aid in the differential diagnosis. Classic features include:

• Ballooning degeneration of keratinocytes: This represents cellular swelling and lysis due to viral cytopathic effect.
• Multinucleated giant cells: Syncytia formation due to viral fusion proteins causing cell-cell fusion.
• Cowdry A inclusions: Eosinophilic intranuclear inclusions, indicative of viral replication, though also found in VZV and CMV infections.

While these findings are suggestive of herpesvirus infection, they are not specific to HSV-1 and cannot reliably differentiate HSV-1 from other herpesviruses or non-infectious conditions. Clinical correlation remains essential.

History and Physical Examination: Clinical Presentations and Differential Clues

A thorough history and physical examination are paramount in the differential diagnosis of HSV-1 infections. Recognizing the distinct clinical presentations and associated differential diagnoses is crucial.

Orolabial Herpes

Presentation: Orolabial herpes, commonly known as cold sores or fever blisters, typically presents as grouped vesicles on an erythematous base, often with a scalloped border, evolving into pustules, erosions, and crusts on the lips or perioral skin. Primary infections in children may manifest as gingivostomatitis with pain, halitosis, and dysphagia, while adults may experience pharyngitis. Recurrent infections are usually milder, localized to the vermillion border, and preceded by a prodrome of tingling, burning, or itching.

Differential Diagnosis:

• Aphthous Stomatitis (Canker Sores): Aphthous ulcers are painful, solitary or multiple, round or oval ulcers with a yellowish-white pseudomembrane and erythematous halo, typically inside the mouth (buccal mucosa, tongue, soft palate), unlike orolabial herpes which is usually outside the mouth (lips, perioral skin). Aphthous ulcers are not vesicular and lack the prodromal tingling seen in herpes.
• Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): These severe mucocutaneous reactions, often drug-induced, can present with widespread mucosal erosions and bullae, including oral lesions. However, SJS/TEN usually involves multiple mucosal sites (oral, ocular, genital) and extensive skin involvement beyond the perioral area, accompanied by systemic symptoms and a history of medication exposure.
• Erythema Multiforme (EM) Major: EM major, often triggered by HSV infection itself, can present with target lesions on the skin and mucosal erosions, including oral involvement. Oral EM lesions are typically erosive and may be hemorrhagic, but lack the grouped vesicles characteristic of primary HSV. Recurrent EM can be confused with recurrent herpes, but EM target lesions are distinctive.
• Herpangina: Caused by Coxsackievirus A, herpangina presents with fever, sore throat, and small vesicles or ulcers on the soft palate, tonsillar pillars, and uvula (posterior oropharynx), sparing the anterior oral mucosa and lips typically affected in orolabial herpes.

Herpetic Sycosis (HSV Folliculitis)

Presentation: Herpetic sycosis presents as follicular papules, pustules, and erosions in the beard area of men, often associated with close shaving. Lesions can range from scattered to confluent, involving the entire beard area.

Differential Diagnosis:

• Bacterial Folliculitis: Bacterial folliculitis, commonly caused by Staphylococcus aureus, also presents with follicular pustules and papules. However, bacterial folliculitis typically lacks the vesicular component and erosions seen in herpetic sycosis. Gram stain and bacterial culture can differentiate bacterial folliculitis.
• Tinea Barbae (Beard Ringworm): Fungal infection of the beard area can present with inflammatory plaques, pustules, and hair loss. KOH examination of skin scrapings can identify fungal hyphae, distinguishing it from herpetic sycosis.
• Pseudofolliculitis Barbae (Razor Bumps): This inflammatory condition results from ingrown hairs, causing papules and pustules, but lacks the vesicular and erosive features of herpetic sycosis. History of shaving technique and absence of vesicles are helpful differentiating factors.

Herpes Gladiatorum

Presentation: Herpes gladiatorum manifests as vesicular lesions on the skin, typically on the face, neck, and trunk, occurring in athletes involved in contact sports.

Differential Diagnosis:

• Bacterial Folliculitis/Impetigo: Bacterial skin infections can mimic herpes gladiatorum, especially in athletes. However, bacterial infections usually lack the grouped vesicles and may present with honey-colored crusting (impetigo). Bacterial culture can differentiate.
• Contact Dermatitis: Irritant or allergic contact dermatitis can cause erythematous papules and vesicles. However, contact dermatitis is typically itchy, lacks the prodromal symptoms of herpes, and often has a distribution related to exposure to a specific irritant or allergen.
• Varicella (Chickenpox): In unvaccinated individuals, varicella can present with widespread vesicular rash. However, varicella vesicles appear in crops at different stages of development (“dewdrops on a rose petal”), are intensely pruritic, and are typically more generalized than herpes gladiatorum.

Herpetic Whitlow

Presentation: Herpetic whitlow presents as painful vesicles and bullae on the fingers or toes, often with surrounding erythema and swelling. Lesions can be deep and erosive, sometimes with associated lymphadenopathy.

Differential Diagnosis:

• Paronychia: Paronychia is a bacterial or fungal infection of the nail fold, presenting with pain, erythema, and swelling around the nail. Acute paronychia may have purulent discharge, while chronic paronychia can cause nail dystrophy. Paronychia typically lacks vesicles and bullae.
• Blistering Dactylitis: Bacterial infection of the distal phalanx, primarily in children, presenting with swelling, erythema, and bullae on the volar aspect of the finger. Blistering dactylitis is usually caused by Group A Streptococcus and lacks the grouped vesicles of herpetic whitlow.
• Dyshidrotic Eczema (Pompholyx): Dyshidrotic eczema presents with intensely pruritic, small vesicles on the palms, soles, and sides of fingers. Dyshidrosis is typically bilateral, more chronic and recurrent, and lacks the pain and erosions often seen in herpetic whitlow.

Ocular HSV Infection (Herpes Keratitis)

Presentation: Ocular HSV infection can manifest as keratoconjunctivitis, blepharitis, or iritis. Herpes keratitis typically presents with unilateral eye pain, redness, photophobia, tearing, and blurred vision. A characteristic dendritic corneal ulcer is pathognomonic for herpetic keratitis.

Differential Diagnosis:

• Bacterial Keratitis: Bacterial corneal infections can present with redness, pain, and purulent discharge. Bacterial keratitis is often associated with contact lens wear or corneal trauma and lacks the dendritic ulcer of HSV keratitis. Corneal scraping and Gram stain/culture are diagnostic.
• Adenoviral Keratoconjunctivitis (Epidemic Keratoconjunctivitis): Adenoviral infection can cause conjunctivitis and keratitis, often with preauricular lymphadenopathy and follicular conjunctivitis. Adenoviral keratitis may present with subepithelial infiltrates, but lacks the dendritic ulcer. Viral culture or PCR can differentiate.
• Corneal Abrasion: Corneal abrasions from trauma can cause pain, tearing, and photophobia. Fluorescein staining can reveal the abrasion, and history of trauma is usually present. Corneal abrasions lack vesicles and dendritic ulcers.
• Uveitis (Non-infectious): Non-infectious uveitis can cause eye pain, redness, and photophobia. However, uveitis typically involves deeper intraocular inflammation without corneal ulceration. Slit-lamp examination and ophthalmological evaluation are crucial to differentiate.

Herpes Encephalitis

Presentation: Herpes encephalitis is a severe neurological emergency presenting with fever, headache, altered mental status, seizures, focal neurological deficits (often temporal lobe signs), and bizarre behavior.

Differential Diagnosis:

• Other Viral Encephalitides: Encephalitis can be caused by other viruses (e.g., enteroviruses, arboviruses, VZV). Epidemiological factors (season, geographic location), specific neurological findings, and CSF analysis (viral PCR, antibody testing) are crucial for differentiation.
• Bacterial Meningitis/Meningoencephalitis: Bacterial infections of the CNS present with fever, headache, stiff neck, and altered mental status. Bacterial meningitis is typically more acute and severe than herpes encephalitis. Lumbar puncture with CSF analysis (Gram stain, culture, cell count, glucose, protein) is essential for rapid differentiation.
• Brain Abscess: Brain abscess can cause focal neurological deficits, headache, and fever. Neuroimaging (CT or MRI) is critical for diagnosis and differentiation from encephalitis.
• Stroke: Acute stroke can present with sudden onset neurological deficits. Neuroimaging (CT or MRI) is essential to distinguish stroke from encephalitis.
• Autoimmune Encephalitis: Autoimmune encephalitis can mimic viral encephalitis, presenting with altered mental status, seizures, and neurological deficits. Specific autoantibody testing and response to immunotherapy can help differentiate.

Eczema Herpeticum (Kaposi Varicelliform Eruption)

Presentation: Eczema herpeticum is a disseminated HSV infection in patients with underlying skin conditions, particularly atopic dermatitis. It presents with rapidly spreading, painful, punched-out erosions and vesicles with hemorrhagic crusts, often accompanied by fever and lymphadenopathy.

Differential Diagnosis:

• Impetiginized Eczema: Secondary bacterial infection of eczema can present with crusting and weeping lesions, mimicking eczema herpeticum. However, impetiginized eczema lacks the characteristic punched-out erosions and vesicles of eczema herpeticum. Bacterial culture and Gram stain can help differentiate.
• Varicella in Patients with Eczema: Varicella infection in patients with eczema can be more severe and extensive, but varicella vesicles are typically more widespread and less erosive than eczema herpeticum. Tzanck smear or viral PCR can differentiate.
• Molluscum Contagiosum: Molluscum contagiosum presents with umbilicated papules, not vesicles or erosions. Clinical appearance and histopathology are usually sufficient for differentiation.

Severe or Chronic HSV Infection in Immunocompromised Patients

Presentation: In immunocompromised individuals, HSV infections can be severe, chronic, and atypical, presenting as persistent ulcerations, verrucous lesions, or disseminated disease involving multiple organ systems (e.g., respiratory, gastrointestinal).

Differential Diagnosis:

• Cytomegalovirus (CMV) Infection: CMV infection is another common opportunistic infection in immunocompromised patients, which can cause similar ulcerations, particularly in the gastrointestinal tract. Biopsy with immunohistochemistry or PCR can differentiate HSV from CMV.
• Fungal Infections: Invasive fungal infections (e.g., candidiasis, aspergillosis) can cause skin lesions and systemic illness in immunocompromised patients. Microscopic examination and fungal cultures are essential.
• Mycobacterial Infections: Atypical mycobacterial infections can present with chronic skin ulcers in immunocompromised individuals. Acid-fast staining and mycobacterial cultures are necessary.
• Drug Reactions: Atypical drug eruptions in immunocompromised patients can mimic chronic HSV lesions. Medication history and skin biopsy can help in differentiation.

Evaluation and Diagnosis

Diagnosis of HSV-1 infection and its differentiation from other conditions relies on a combination of clinical evaluation and laboratory testing:

• Viral Culture: Historically the gold standard, viral culture is less sensitive and slower than PCR, but can still be useful.
• Viral PCR: Polymerase Chain Reaction is the most sensitive and specific method for detecting HSV-1 DNA in lesion swabs, CSF, or tissue samples. PCR is particularly useful for diagnosing herpes encephalitis and atypical presentations.
• Direct Fluorescent Antibody (DFA) Assay: DFA is a rapid test to detect HSV antigens in lesion scrapings, allowing for differentiation between HSV and VZV.
• Tzanck Smear: A rapid but non-specific test that identifies multinucleated giant cells, indicative of herpesvirus infection but cannot distinguish between HSV and VZV.
• HSV Serology (Antibody Detection): Serology can detect past HSV-1 infection but is less helpful in acute diagnosis. IgM and IgG antibody testing can differentiate primary from recurrent infection in some cases, but serology is not reliable for diagnosing active infection.

Treatment and Management

Antiviral therapy with acyclovir, valacyclovir, or famciclovir is the mainstay of treatment for significant HSV-1 infections. Prompt treatment, especially for herpes encephalitis and eczema herpeticum, is crucial. For orolabial herpes, topical or oral antivirals can shorten the duration and severity of outbreaks. Chronic suppressive antiviral therapy may be considered for frequent recurrences or in immunocompromised patients. Management also involves supportive care, pain relief, and prevention of secondary bacterial infections.

Prognosis

The prognosis of HSV-1 infection varies widely depending on the clinical manifestation. Orolabial herpes and herpetic whitlow are usually self-limiting with a good prognosis, although recurrences are common. Herpes encephalitis has a high mortality rate if untreated, but prompt antiviral therapy improves outcomes. Ocular HSV can lead to corneal scarring and blindness if not managed effectively. In immunocompromised patients, severe or chronic HSV infections can be life-threatening.

Enhancing Healthcare Team Outcomes

Effective management of herpes simplex differential diagnosis requires a collaborative interprofessional team. Primary care providers, pediatricians, nurse practitioners, infectious disease specialists, ophthalmologists, and neurologists may be involved in the care of patients with HSV-1 infection. Early recognition, accurate diagnosis, and prompt antiviral therapy are essential to improve patient outcomes and minimize complications. Patient education regarding transmission prevention and self-care measures is also crucial.

Review Questions

1. Which of the following is the most reliable method to differentiate between orolabial herpes and aphthous stomatitis?
   a) Tzanck smear
   b) Location of lesions (inside vs. outside the mouth)
   c) Viral culture
   d) HSV serology

2. A patient presents with painful vesicles on the finger. Which differential diagnosis is most important to consider and rule out?
   a) Herpes gladiatorum
   b) Paronychia
   c) Eczema herpeticum
   d) Aphthous ulcer

3. What is the pathognomonic finding for ocular herpes simplex keratitis?
   a) Corneal neovascularization
   b) Preauricular lymphadenopathy
   c) Dendritic corneal ulcer
   d) Chemosis

Answer Key: 1: b, 2: b, 3: c

Image alt text: Clinical manifestations of herpes simplex virus infection on the face, showing vesicular lesions, erythema, and crusting.

Image alt text: Clinical features of herpes simplex keratitis including corneal neovascularization and dendritic ulcers visualized with fluorescein staining.

Image alt text: Erythematous vesiculopapular lesions characteristic of a herpes genitalis outbreak on the penile shaft.

Image alt text: Close-up view of genital herpes lesions presenting as vesicles and ulcers on the penis.

Image alt text: Orolabial herpes simplex infection showing typical vesicles and crusting on the lip and perioral skin.

References

1.Rechenchoski DZ, Faccin-Galhardi LC, Linhares REC, Nozawa C. Herpesvirus: an underestimated virus. Folia Microbiol (Praha). 2017 Mar;62(2):151-156. [PubMed: 27858281]

2.Soriano V, Romero JD. Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS. AIDS Rev. 2018;20(4):187-204. [PubMed: 30548023]

3.Mostafa HH, Thompson TW, Konen AJ, Haenchen SD, Hilliard JG, Macdonald SJ, Morrison LA, Davido DJ. Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation. J Virol. 2018 Apr 01;92(7) [PMC free article: PMC5972887] [PubMed: 29321311]

4.Pfaff F, Groth M, Sauerbrei A, Zell R. Genotyping of herpes simplex virus type 1 by whole-genome sequencing. J Gen Virol. 2016 Oct;97(10):2732-2741. [PubMed: 27558891]

5.van Oeffelen L, Biekram M, Poeran J, Hukkelhoven C, Galjaard S, van der Meijden W, Op de Coul E. Update on Neonatal Herpes Simplex Epidemiology in the Netherlands: A Health Problem of Increasing Concern? Pediatr Infect Dis J. 2018 Aug;37(8):806-813. [PubMed: 29356762]

6.Chaabane S, Harfouche M, Chemaitelly H, Schwarzer G, Abu-Raddad LJ. Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions. Sci Rep. 2019 Feb 04;9(1):1136. [PMC free article: PMC6362060] [PubMed: 30718696]

7.Fedoreyev SA, Krylova NV, Mishchenko NP, Vasileva EA, Pislyagin EA, Iunikhina OV, Lavrov VF, Svitich OA, Ebralidze LK, Leonova GN. Antiviral and Antioxidant Properties of Echinochrome A. Mar Drugs. 2018 Dec 15;16(12) [PMC free article: PMC6315383] [PubMed: 30558297]

8.Jiang Y, Leib D. Preventing neonatal herpes infections through maternal immunization. Future Virol. 2017 Dec;12(12):709-711. [PMC free article: PMC5751513] [PubMed: 29339967]

9.Marchi S, Trombetta CM, Gasparini R, Temperton N, Montomoli E. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J Prev Med Hyg. 2017 Mar;58(1):E27-E33. [PMC free article: PMC5432775] [PubMed: 28515628]

10.Finger-Jardim F, Avila EC, da Hora VP, Gonçalves CV, de Martinez AMB, Soares MA. Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women. Am J Reprod Immunol. 2017 Jul;78(1) [PubMed: 28440579]

11.Rosenberg J, Galen BT. Recurrent Meningitis. Curr Pain Headache Rep. 2017 Jul;21(7):33. [PubMed: 28551737]

12.Cruz AT, Freedman SB, Kulik DM, Okada PJ, Fleming AH, Mistry RD, Thomson JE, Schnadower D, Arms JL, Mahajan P, Garro AC, Pruitt CM, Balamuth F, Uspal NG, Aronson PL, Lyons TW, Thompson AD, Curtis SJ, Ishimine PT, Schmidt SM, Bradin SA, Grether-Jones KL, Miller AS, Louie J, Shah SS, Nigrovic LE., HSV Study Group of the Pediatric Emergency Medicine Collaborative Research Committee. Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation. Pediatrics. 2018 Feb;141(2) [PMC free article: PMC5810597] [PubMed: 29298827]

13.Zhang J, Liu H, Wei B. Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection. 2017 Apr.J Zhejiang Univ Sci B. 18(4):277-288. [PMC free article: PMC5394093] [PubMed: 28378566]

14.Giraldo D, Wilcox DR, Longnecker R. The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection. DNA Cell Biol. 2017 May;36(5):329-334. [PMC free article: PMC5421632] [PubMed: 28278385]

15.Rajasagi NK, Rouse BT. Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy. Microbes Infect. 2018 Oct-Nov;20(9-10):526-530. [PMC free article: PMC6037561] [PubMed: 29329934]

16.Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, Leung DYM. Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum. J Allergy Clin Immunol. 2018 Jun;141(6):2085-2093.e1. [PMC free article: PMC5994174] [PubMed: 29371118]

17.Darji K, Frisch S, Adjei Boakye E, Siegfried E. Characterization of children with recurrent eczema herpeticum and response to treatment with interferon-gamma. Pediatr Dermatol. 2017 Nov;34(6):686-689. [PubMed: 29144049]

18.Wei EY, Coghlin DT. Beyond Folliculitis: Recognizing Herpes Gladiatorum in Adolescent Athletes. J Pediatr. 2017 Nov;190:283. [PubMed: 28728810]

19.Williams C, Wells J, Klein R, Sylvester T, Sunenshine R., Centers for Disease Control and Prevention (CDC). Notes from the field: outbreak of skin lesions among high school wrestlers–Arizona, 2014. MMWR Morb Mortal Wkly Rep. 2015 May 29;64(20):559-60. [PMC free article: PMC4584520] [PubMed: 26020140]

20.Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ikhevha Ogah J. Seroprevalence and Co-Infection of Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus (HSV) Among Pregnant Women in Lokoja, North-Central Nigeria. Iran Red Crescent Med J. 2016 Oct;18(10):e25284. [PMC free article: PMC5286443] [PubMed: 28180012]

21.El Hayderi L, Rübben A, Nikkels AF. The alpha-herpesviridae in dermatology : Herpes simplex virus types I and II. Hautarzt. 2017 Dec;68(Suppl 1):1-5. [PubMed: 28197698]

22.Shenoy R, Mostow E, Cain G. Eczema herpeticum in a wrestler. Clin J Sport Med. 2015 Jan;25(1):e18-9. [PubMed: 24714395]

23.Li Z, Breitwieser FP, Lu J, Jun AS, Asnaghi L, Salzberg SL, Eberhart CG. Identifying Corneal Infections in Formalin-Fixed Specimens Using Next Generation Sequencing. Invest Ophthalmol Vis Sci. 2018 Jan 01;59(1):280-288. [PMC free article: PMC5770184] [PubMed: 29340642]

24.El Hayderi L, Rübben A, Nikkels AF. [The alpha-herpesviridae in dermatology : Herpes simplex virus types I and II. German version]. Hautarzt. 2017 Mar;68(3):181-186. [PubMed: 28197699]

25.Sanders JE, Garcia SE. Pediatric herpes simplex virus infections: an evidence-based approach to treatment. Pediatr Emerg Med Pract. 2014 Jan;11(1):1-19; quiz 19. [PubMed: 24649621]

26.Kalogeropoulos D, Geka A, Malamos K, Kanari M, Kalogeropoulos C. New Therapeutic Perceptions in a Patient with Complicated Herpes Simplex Virus 1 Keratitis: A Case Report and Review of the Literature. Am J Case Rep. 2017 Dec 27;18:1382-1389. [PMC free article: PMC5753617] [PubMed: 29279602]

27.Anderson BJ, McGuire DP, Reed M, Foster M, Ortiz D. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review. Clin J Sport Med. 2016 Jul;26(4):272-8. [PubMed: 26540599]

28.Mir-Bonafé JM, Román-Curto C, Santos-Briz A, Palacios-Álvarez I, Santos-Durán JC, Fernández-López E. Eczema herpeticum with herpetic folliculitis after bone marrow transplant under prophylactic acyclovir: are patients with underlying dermatologic disorders at higher risk? Transpl Infect Dis. 2013 Apr;15(2):E75-80. [PubMed: 23387866]

29.Gottlieb SL, Giersing BK, Hickling J, Jones R, Deal C, Kaslow DC., HSV Vaccine Expert Consultation Group. Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017. Vaccine. 2019 Nov 28;37(50):7408-7418. [PubMed: 29224963]